Efficacy and Safety of Cefoperazone/sulbactam in Treatment of Lower Respiratory Tract Infections of Elderly: A Clinical Study Compared with Cefoperazone
Wang Xiao-ge
Abstract
Wang Xiao-ge
Abstract
OBJECTIVE To evaluate the efficacy and safety of cefoperazone/sulbactam in comparison with cefoperazone in(treatment) of lower respiratory tract infections of elderly.METHODS Eighty six patients((seventy) years old) with lung infections were equally divided into two groups:cefoperazone/sulbactam group and cefoperazone group in a regimen of 1.0-2.0 g,twice daily for 5-14 days.RESULTS The effective rate of both agents were 100% and 80%,and their ADRs incidence rate of elderly was 4.98% and 25.00%, respectively.There were statistically significant difference(P(0.05)).CONCLUSIONS From results of this study it can be(concluded) that cefoperazone/sulbactam is an effective and safe drug for treatment of lung infection of elderly.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To evaluate the efficacy and safety of cefoperazone/sulbactam in comparison with cefoperazone in(treatment) of lower respiratory tract infections of elderly.METHODS Eighty six patients((seventy) years old) with lung infections were equally divided into two groups:cefoperazone/sulbactam group and cefoperazone group in a regimen of 1.0-2.0 g,twice daily for 5-14 days.RESULTS The effective rate of both agents were 100% and 80%,and their ADRs incidence rate of elderly was 4.98% and 25.00%, respectively.There were statistically significant difference(P(0.05)).CONCLUSIONS From results of this study it can be(concluded) that cefoperazone/sulbactam is an effective and safe drug for treatment of lung infection of elderly.
Key concepts: Cefoperazone, Medicine, Sulbactam, Internal medicine, Regimen, Incidence (geometry), Respiratory tract infections, Respiratory tract